Guangzhou, China · Founded 2019 · Privately Held (backing)
Developer of pharmaceutical drugs intended for global pharmaceutical markets and healthcare providers. MingMed Biotech is based in Guangzhou, China and was founded in 2019. Its last reported valuation was $615 million in Jul 2022. It has raised $140 million.
Last reported valuation
$615.4M
Oct 2026
Priced at
—
Total raised
$139.8M
Last round
—
Team — not yet on record
No current team members for MingMed Biotech are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of MingMed Biotech with a free account
·The complete investor list: 16 names
·Watch MingMed Biotech: the Monday email on marks, rounds and moves
